Cargando…
Real-Time Characterization of Clonal Fate Decisions in Complex Leukemia Samples by Fluorescent Genetic Barcoding
Clonal heterogeneity in acute myeloid leukemia (AML) forms the basis for treatment failure and relapse. Attempts to decipher clonal evolution and clonal competition primarily depend on deep sequencing approaches. However, this prevents the experimental confirmation of the identified disease-relevant...
Autores principales: | Maetzig, Tobias, Lieske, Anna, Dörpmund, Nicole, Rothe, Michael, Kleppa, Marc-Jens, Dziadek, Violetta, Hassan, Jacob Jalil, Dahlke, Julia, Borchert, Dorit, Schambach, Axel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776743/ https://www.ncbi.nlm.nih.gov/pubmed/36552809 http://dx.doi.org/10.3390/cells11244045 |
Ejemplares similares
-
A Multiplex CRISPR-Screen Identifies PLA2G4A as Prognostic Marker and Druggable Target for HOXA9 and MEIS1 Dependent AML
por: Hassan, Jacob Jalil, et al.
Publicado: (2021) -
A pro B cell population forms the apex of the leukemic hierarchy in Hoxa9/Meis1-dependent AML
por: Lieske, Anna, et al.
Publicado: (2022) -
Lentiviral Fluorescent Genetic Barcoding for Multiplex Fate Tracking of Leukemic Cells
por: Maetzig, Tobias, et al.
Publicado: (2017) -
Competitive sgRNA Screen Identifies p38 MAPK as a Druggable Target to Improve HSPC Engraftment
por: Klatt, Denise, et al.
Publicado: (2020) -
Gammaretroviral Vectors: Biology, Technology and Application
por: Maetzig, Tobias, et al.
Publicado: (2011)